Theglobal 'peptic ulcer drugsmarket size’ is projected to showcase exponential growth by reachingUSD 5.13 billion by 2027 while exhibiting a CAGR of 2.4% between 2020 and 2027.This is attributable to the increasing prevalence of peptic ulcer disease andthe growing demand for effective peptic ulcer drugs across the globe. FortuneBusiness Insights, in its latest report, titled, “Peptic Ulcer Drugs MarketSize, Share & COVID-19 Imapct Analysis, By Drugs Type (Proton PumpInhibitor (PPI), H2 Antagonists, Antibiotics, and Others), By Ulcer Type(Gastric Ulcer and Duodenal Ulcer), By Distribution Channel (HospitalPharmacies, Retail Pharmacies, and Online Pharmacies), and Regional Forecast,2020-2027.”, mentions that the market was valued at USD 4.25 billion in 2019and is likely to gain momentum in the forthcoming years.
Request a Sample Copy of the Research Report:
https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/peptic-ulcer-drugs-market-103483
Soaring Demand for Peptic Ulcer Drugs In spite of COVID-19Pandemic
TheCOVID-19 pandemic has led to the halt of several industrial processes causingunprecedented economic loss. However, pharmaceutical companies are thriving inthese difficult times owing to the increasing demand for medication drugsacross the globe. Likewise, the demand for these ulcer drugs is experiencingconsiderable growth as major pharmaceutical companies are increasing theirfocus on R&D activities to develop new drugs and cater to the demand forthe OTC drugs across several stores. The market is, therefore, expected toshowcase positive growth during the forecast period.
What does the Report Include?
Themarket report includes quantitative and qualitative analysis of several factorssuch as the key drivers and restraints that will impact growth. Additionally,the report provides insights into the regional analysis that covers differentregions, which are contributing to the growth of the market. It includes thecompetitive landscape that involves leading companies and the adoption ofstrategies by them to introduce new products, announce partnerships, andcollaboration that will contribute to the growth of the market between 2020 and2027. Moreover, the research analyst has adopted several research methodologiessuch as PESTEL and SWOT analysis to extract information about the currenttrends and industry developments that will drive the market growth in theforthcoming years.
An Overview of the Impact of COVID-19 on this Market :
Theemergence of COVID-19 has brought the world to a standstill. We understand thatthis health crisis has brought an unprecedented impact on businesses acrossindustries. However, this too shall pass. Rising support from governments andseveral companies can help in the fight against this highly contagious disease.There are some industries that are struggling and some are thriving. Overall,almost every sector is anticipated to be impacted by the pandemic.
Weare taking continuous efforts to help your business sustain and grow duringCOVID-19 pandemics. Based on our experience and expertise, we will offer you animpact analysis of corona virus outbreak across industries to help you preparefor the future.
Frequently Ask Question :
1) How much is the pepticulcer drugs market worth?
Fortune Business Insightssays that the global Peptic Ulcer Drugs market size was USD 4.25 billion in2019 and is projected to reach USD 5.13 billion by 2027.
2) What was the value of themarket in North America in 2019?
In 2019, the North Americamarket value stood at USD 1.76 billion.
3) At what CAGR is the marketprojected to grow in the forecast period (2020-2027)?
Growing at a CAGR of 2.4%, the marketwill exhibit steady growth in the forecast period (2020-2027).
For more information visit : https://www.fortunebusinessinsights.com/peptic-ulcer-drugs-market-103483
Table Of Content :
- Introduction
- Research Scope
- Market Segmentation
- Research Methodology
- Definitions and Assumptions
- Executive Summary
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Key Insights
- Prevalence of Peptic Ulcer, By Country/Region
- Pipeline Analysis, By Key Players
- Recent Industry Developments
- Regulatory Scenario-by Key Countries
- Impact of COVID-19 on Peptic Ulcer Drugs Market
Continue…
DRIVING FACTORS
Increasing Prevalence of Peptic Ulcer Disease to Spur Demand
Accordingto the Harvard Health Publishing, every year peptic ulcers affect more than 4million people in the U.S. Additionally, it occurs irrespective of the agebracket, and is estimated that 1 in 10 individuals are likely to develop thisdisease at some point of their life. The increasing prevalence of peptic ulcerdisease is driving the demand for effective peptic ulcer drugs across theglobe. Furthermore, the growing geriatric population is expected to contributeto the growth of the global peptic ulcer drugs market in the forthcoming years.
REGIONAL ANALYSIS
Increasing Incidence of Disease in North America to Aid Growth
Amongall the regions, North America was worth USD 1.76 billion in 2019 and isexpected to hold the highestmarket share in the forthcoming years. This isattributable to the increasing incidence of peptic ulcers in the U.S. thatdrives the demand for peptic ulcer drugs in the region. On the other hand,Europe is anticipated to hold the second position during the forecast period.This is ascribable to factors such as the rising healthcare expenditure incountries such as the U.K., France, and Germany between 2020 and 2027.
COMPETITIVE LANDSCAPE:
Product Launches by Major Companies to Strengthen TheirPortfolios
Theglobal peptic ulcer drugs market is mainly dominated by major companies such asPfizer, Inc., and AstraZeneca. These companies are actively investing inR&D activities to introduce new products and maintain their dominance inthe global marketplace. Furthermore, the other key players are adoptingstrategies such as collaboration, partnership, and merger and acquisition tomaintain their presencein the fiercely competitive market during the forecastperiod.
Industry Development:
- March 2020: RedHill Biopharma announced the commercial launch in the U.S. of Talicia, a capsule to treat H.pylori infection in patients. The announcement by the leading pharma company is expected to strengthen its market position in the near future.
List of the Companies Operating in the Global Market
- AstraZeneca (Cambridge, United Kingdom)
- Novartis AG (Basel, Switzerland)
- Pfizer Inc. (New York, United States)
- GlaxoSmithKline plc. (Brentford, United Kingdom)
- Takeda Pharmaceutical Company Limited. (Tokyo, Japan)
- Mylan Pharmaceuticals Inc. (Canonsburg, Pennsylvania, United States)
- Abbott (Illinois, United States)
- ZydusCadila (Gujrat, India)
- Other Players
Have Any Query? Ask Our Experts:
https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/peptic-ulcer-drugs-market-103483
Segments Covered in the Report
By Drug Type
- Proton Pump Inhibitors
- H2 Antagonists
- Antibiotics
- Others
By Ulcer Type
- Gastric Ulcer
- Duodenal Ulcer
By End User
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Geography
- North America
- By Drug Type
- By Ulcer Type
- By End User
- By Country
Related Reports:
About Us:
Fortune Business Insights(TM) offers expert corporate analysis and accuratedata, helping organizations of all sizes make timely decisions. We tailorinnovative solutions for our clients, assisting them to address challengesdistinct to their businesses. Our goal is to empower our clients with holisticmarket intelligence, giving a granular overview of the market they areoperating in.
Our reports contain a unique mix of tangible insights and qualitative analysisto help companies achieve sustainable growth. Our team of experienced analystsand consultants use industry-leading research tools and techniques to compilecomprehensive market studies, interspersed with relevant data.
At Fortune Business Insights(TM) we aim at highlighting the most lucrativegrowth opportunities for our clients. We, therefore, offer recommendations,making it easier for them to navigate through technological and market-relatedchanges. Our consulting services are designed to help organizations identifyhidden opportunities and understand prevailing competitive challenges
Contact Us:
Fortune Business Insights(TM) Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
